Entera Bio Corp (ENTX): Nilai Total Aset Perusahaan

Logo grafis enterabio.com (ENTX)

The price characteristics of Entera Bio Ltd. (ENTX) total assets, with a value of 19.57, highlight the biotech firm's dependence on external investments and FDA verdicts in developing oral protein delivery systems. The business relies on automated pill synthesis, where IT algorithms are supplemented by medical expertise. Future revenue is tied to B2B licensing of patented technologies for industry behemoths, as the company currently lacks market control.

Total Aset Perusahaan Entera Bio (ENTX): kanggo periode 04.07.2022 - 28.10.2026

Rincian metrik komprehensif lan analitis enterabio.com (ENTX)

- rega lan prakiraan konsensus rega:
Kurs saham Entera Bio|ENTX - Bagan rega target
- data kapitalisasi pasar:
Biji pasar ENTX|ENTX - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Entera Bio|ENTX - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku enterabio.com|ENTX - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Entera Bio Ltd.|ENTX - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Entera Bio|ENTX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ENTX|ENTX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Entera Bio
Pambiji fundamental:ENTX, Entera Bio Corp
Produk dadi Entera Bio Ltd

Retaining key peptide developers through stock option programs minimizes recruitment capital expenditures, which stabilizes the resource base of Entera Bio Ltd. (ENTX). The current trend of gross assets, reverse-calculated via return on assets (ROA), reflects the aggregate of assets and liabilities, allowing investors to assess the resilience of the company's balance sheet mass against inflationary costs on a daily planning horizon.

Pesaing Entera Bio Ltd. (ENTX)

HLN (haleon.com) - Total Aset Bisnis|Aset Agregat Perusahaan Kenvue KVUE|Nilai Total Aset Perusahaan Verona Pharma PLC|Jyong Biotech Corp (MENS) - Total Aset Perusahaan|Nilai Agregat Aset Ligand Corp (LGND)|Total Aset Perusahaan AMRX (Amneal Pharmaceuticals)|perrigo.com - Total Aset Perusahaan|Aset Agregat Perusahaan Alvotech SA (ALVO)|LQDA: Nilai Agregat Aset|GLPG (Galapagos Genomics) - Aset Agregat Perusahaan|ANI Pharmaceuticals Corp (ANIP) - Gunggung Aset Perusahaan|MNKD (MannKind Corporation) - Total Aset Perusahaan|Total Aset Perusahaan amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Gunggung Aset Perusahaan|Nilai Agregat Aset SPRY (ARS Pharmaceuticals Inc)|TBPH: Aset Agregat Perusahaan|AQST - Aset Perusahaan|Gunggung Aset Perusahaan scPharma SCPH|TECX - Aset Agregat Bisnis|Total Aset Perusahaan Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Nilai Agregat Aset|Total Aset Perusahaan EPRX (Eupraxia Pharmaceuticals, Inc.)|Aset Perusahaan BHST|eXoZymes Inc (EXOZ) - Aset Agregat Perusahaan|Nilai Agregat Aset oramed.com (ORMP)|HYFT: Total Aset Perusahaan|ABVC BioPharma Inc. - Aset Perusahaan|Cumberland Pharma (CPIX) - Aset Agregat Perusahaan|Quantum BioPharma Corp (QNTM) - Total Aset Bisnis|FGEN - Gunggung Aset Perusahaan|telomirpharma.com (TELO) - Aset Agregat Bisnis|Total Aset Perusahaan RANI (Rani Therapeutics Holdings)|Aset Perusahaan SNYR|Rallybio Corporation (RLYB) - Aset Agregat Perusahaan|Nilai Agregat Aset lexariabioscience.com (LEXX)|Total Aset Perusahaan PULM (Pulmatrix, Inc.)|PTHL - Total Aset Perusahaan|Gunggung Aset Perusahaan Aptorum (APM)|LYRA - Nilai Agregat Aset|Impact BioMedical (IBO) - Total Aset Perusahaan|TNF Pharmaceuticals, Inc. (TNFA) - Aset Agregat Perusahaan|YCBD: Total Aset Perusahaan|Gunggung Aset Perusahaan PRFX|Altamira Therapeutics - Aset Agregat Perusahaan|Aset Perusahaan Lipella Pharmaceuticals Inc LIPO|Gunggung Aset Perusahaan Optinose|Pieris Pharma - Nilai Agregat Aset|PROC - Aset Agregat Perusahaan|petrospharma.com (PTPI) - Aset Agregat Perusahaan|QLI - Gunggung Aset Perusahaan|Acelyrin Inc. (SLRN) - Aset Agregat Bisnis|Total Aset Perusahaan TFF Pharma (TFFP)